Price T Rowe Associates Inc Prime Medicine, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,522,590 shares of PRME stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,522,590

Previous 2,221,159 13.57%

Holding current value

$13 Million

Previous $19.7 Million 10.27%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.35 - $9.39 $1.91 Million - $2.83 Million	301,431 Added 13.57%	2,522,590 $17.7 Million
Q4 2023 Feb 14, 2024	BUY	$5.59 - $9.55 $267,134 - $456,375	47,788 Added 2.2%	2,221,159 $19.7 Million
Q3 2023 Nov 14, 2023	SELL	$9.5 - $15.07 $1.52 Million - $2.42 Million	-160,460 Reduced 6.88%	2,173,371 $20.7 Million
Q2 2023 Aug 14, 2023	BUY	$11.41 - $17.05 $16.3 Million - $24.4 Million	1,430,090 Added 158.24%	2,333,831 $34.2 Million
Q1 2023 May 15, 2023	SELL	$11.21 - $21.11 $16.5 Million - $31.1 Million	-1,474,841 Reduced 62.01%	903,741 $11.1 Million

Q4 2022 Feb 14, 2023	BUY	$16.24 - $21.12 $38.6 Million - $50.2 Million	2,378,582 New	2,378,582 $44.2 Million

Others Institutions Holding PRME

# of Institutions

120

Shares Held

62.6M

Call Options Held

57.7K

Put Options Held

66.3K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $492M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Prime Medicine, Inc. Transaction History